Lisata Therapeutics Correlations
LSTA Stock | USD 2.50 0.00 0.00% |
The current 90-days correlation between Lisata Therapeutics and Imunon Inc is 0.11 (i.e., Average diversification). The correlation of Lisata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Lisata Therapeutics Correlation With Market
Good diversification
The correlation between Lisata Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lisata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Lisata |
Moving together with Lisata Stock
0.62 | ALTS | ALT5 Sigma Symbol Change | PairCorr |
Moving against Lisata Stock
0.53 | EHC | Encompass Health Corp Earnings Call This Week | PairCorr |
0.49 | DERM | Journey Medical Corp Upward Rally | PairCorr |
0.48 | NHC | National HealthCare | PairCorr |
0.47 | ENSG | Ensign Group | PairCorr |
0.42 | MD | Mednax Inc | PairCorr |
0.42 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
0.42 | PNTG | Pennant Group | PairCorr |
0.36 | JNJ | Johnson Johnson | PairCorr |
0.33 | INNV | InnovAge Holding Corp Earnings Call This Week | PairCorr |
0.65 | 300871 | Wuhan Hvsen Biotechnology | PairCorr |
0.61 | 300439 | Ningbo MedicalSystem | PairCorr |
0.59 | 688739 | Liaoning Chengda Bio | PairCorr |
0.58 | 688217 | Shanghai Rightongene | PairCorr |
0.58 | VLY | Valley National Bancorp | PairCorr |
0.53 | 688670 | Jiangsu GDK Biotechnology | PairCorr |
0.5 | 688639 | Anhui Huaheng Biotec | PairCorr |
0.45 | 300942 | Shenzhen Bioeasy Bio | PairCorr |
0.43 | 301301 | Yili Chuanning Biote | PairCorr |
0.34 | BRK-B | Berkshire Hathaway | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lisata Stock performing well and Lisata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lisata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LIXT | 5.17 | 1.19 | 0.15 | (0.66) | 5.37 | 12.61 | 78.53 | |||
HSTO | 5.31 | (1.05) | 0.00 | 0.35 | 0.00 | 10.80 | 93.31 | |||
IMNN | 3.14 | 0.10 | 0.00 | (0.28) | 3.53 | 7.87 | 24.53 | |||
KA | 5.10 | (0.18) | 0.00 | 0.31 | 0.00 | 10.45 | 41.46 | |||
RZLT | 2.86 | (0.09) | 0.00 | (0.05) | 0.00 | 6.80 | 19.56 | |||
CYT | 2.76 | 0.61 | 0.13 | (1.25) | 2.57 | 10.00 | 36.14 | |||
XOMAO | 0.23 | 0.01 | (0.28) | (0.61) | 0.24 | 0.52 | 1.48 | |||
PTIX | 6.52 | (0.41) | 0.00 | 2.58 | 0.00 | 14.29 | 48.67 | |||
TPST | 3.20 | (0.23) | 0.00 | (0.04) | 0.00 | 5.56 | 24.26 | |||
PULM | 6.31 | 2.82 | 0.47 | (1.10) | 4.08 | 16.69 | 92.85 |
Lisata Therapeutics Corporate Management
Kristen MD | Executive Officer | Profile | |
Gail Holler | Vice Resources | Profile | |
James Nisco | Treasurer, Finance | Profile | |
Tariq Imam | Vice Counsel | Profile | |
Ian MBA | Inc NeoStem | Profile | |
Gregory Berkin | Chief Officer | Profile | |
John Menditto | Vice Communications | Profile |